AMB-CHMINACA

AMB-CHMINACA
Systematic (IUPAC) name
	Methyl 2-{[1-(cyclohexylmethyl)-1H-indazole-3-carbonyl]amino}-3-methylbutanoate
Clinical data
Legal status	CA: Schedule II;
Identifiers
CAS Number	1863066-03-8
ChemSpider	32055578
Chemical data
Formula	C21H29N3O3
Molecular mass	371.5 g/mol
	SMILES O=C(N[C@@H](C(C)C)C(OC)=O)C1=NN(CC2CCCCC2)C3=C1C=CC=C3 ;
	InChI InChI=1S/C21H29N3O3/c1-14(2)18(21(26)27-3)22-20(25)19-16-11-7-8-12-17(16)24(23-19)13-15-9-5-4-6-10-15/h7-8,11-12,14-15,18H,4-6,9-10,13H2,1-3H3,(H,22,25) ; Key:CRGGXDSTBHQLKJ-UHFFFAOYSA-N ;

AMB-CHMINACA (also known as MA-CHMINACA) is an indazole-based synthetic cannabinoid that is presumed to be a agonist of the CB₁ receptor and has been sold online as a designer drug.^[1]^[2]

Legal status

AMB-CHMINACA is listed in the Fifth Schedule of the Misuse of Drugs Act (MDA) and therefore illegal in Singapore as of May 2015.^[3]

This cannabinoid related article is a stub. You can help Wikipedia by expanding it.